Welcome To ORINOVE INC.
Solving unmet medical needs with innovative medicine
Orinove Inc., is a pharmaceutical company focused on novel products for the treatment of unmet medical needs and serious diseases.
Trusted by 25,000+ world-class brands and organizations of all sizes
Happy Customer
Product Sold
Years Experience
About Us
We Are A Pharmaceutical Company
Orinove Inc., is a pharmaceutical company focused on novel products for the treatment of unmet medical needs and serious diseases.
ORIN1001 is the lead proprietary oral drug candidate for the treatment of cancer and IPF (idiopathic pulmonary fibrosis).
Mi est nunc lacus cursus malesuada luctus enim. Euismod convallis ligula pede feugiat integer sem vehicula cursus.
Mi est nunc lacus cursus malesuada luctus enim. Euismod convallis ligula pede feugiat integer sem vehicula cursus.
Mi est nunc lacus cursus malesuada luctus enim. Euismod convallis ligula pede feugiat integer sem vehicula cursus.
Technology
A pharmacy with world-class service.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Porta platea litora orci felis magna maximus euismod nunc semper
What We offer
A pharmacy with world-class service.
ORIN1001: A new way to treat cancer.
ORIN1001: A promising way to treat pulmonary fibrosis and other serious diseases
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Intrinsic for cell survival during times of extreme stress such as cancer, chemotherapy and fibrosis.
Activation of the IRE1 pathway in cancer and IPF. Thus, blocking this pathway results in reduction in advanced tumors and fibrosis progression.
A small molecule inhibitor of the IRE1 pathway for the treatment of various cancers, including breast cancer, and fibrosis disorders.
Our Technology
ORIN1001: A new way to treat cancer
Meet Our Leadership Team
Send Us A Note
To contact us about our ongoing clinical trials or investor opportunities, please contact us below.